Skip to main content

Advertisement

SpringerLink
Log in

Role of propranolol in ulcerated haemangioma of head and neck: a prospective comparative study

  • Original Article
  • Published:
Oral and Maxillofacial Surgery Aims and scope Submit manuscript

Abstract

Purpose

Infantile haemangiomas comprise the majority of vascular anomalies and are considered the predominant vascular tumour type 1. We performed this prospective study to evaluate the therapeutic response and propranolol tolerance in infants with ulcerated infantile haemangioma of head and neck region.

Methods

Sixty-four patients with ulcerated infantile haemangiomas (IHs) of head and neck region, without any prior treatment and with age older than 1 month, were included in the study, after informed consent was obtained, and were randomly divided into groups A and B. Group A patients were given oral propranolol at a dose of 2 mg/kg per day in three divided doses as outpatients. Group B patients were given oral ibuprofen at a dose of 10 mg/kg 8-hourly and paracetamol at dose of 16.2 mg/kg 8-hourly. Documentation of gender, age, haemangioma location, duration of ulceration and pain was measured on the second and fifth day after commencement of treatment in both groups using the Children’s Hospital of Eastern Ontario Pain Scale.

Results

There was no difference in pain score between the two groups (P value 0.074). Mean duration of healing of ulceration in group A was 17.93 ± 2.22 days and in group B was 27.71 ± 2.33 days (P value <0.001). In group A, out of 28 patients, 8 (28.5 %) were complete responders, 16 (57.1 %) were partial responders and 4 (14.2 %) were non-responders.

Conclusion

Propranolol is a valuable therapeutic alternative for treatment of ulcerated haemangiomas and effectively reduces pain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Picture 1
Flowchart 1

Similar content being viewed by others

References

  1. Buckmiller LM, Munson PD, Dyamenahalli U, Dai Y, Richter GT (2010) Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope 120:676–681

    Article  CAS  PubMed  Google Scholar 

  2. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taıeb A (2008) Propranolol for severe hemangiomas of infancy. N Engl J Med 358:2649–2651

    Article  CAS  PubMed  Google Scholar 

  3. Buckmiller LM (2009) Propranolol treatment for infantile hemangiomas. Curr Opin Otolaryngol Head Neck Surg 17:458–459

    Article  PubMed  Google Scholar 

  4. Siegfried EC, Keenan WJ, Al Jureidini S (2008) More on propranolol for hemangiomas of infancy. N Engl J Med 359:2846–2847

    Article  CAS  PubMed  Google Scholar 

  5. Naouri M, Schill T, Maruani A et al (2010) Successful treatment of ulcerated haemangioma with propranolol. J Eur Acad Dermatol Venereol 24(9):1109–1112

    CAS  PubMed  Google Scholar 

  6. Kim HJ, Colombo M, Frieden IJ et al (2001) Ulcerated hemangiomas: clinical characteristics and response to therapy. J Am Acad Dermatol 44:962–972

    Article  CAS  PubMed  Google Scholar 

  7. Kima HCL, Hogeling M, Wargon O, Ashish Jiwane A, Adamsa S (2011) Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas. J Pediatr Surg 46:759–763

    Article  Google Scholar 

  8. Jean MS, Labreze CL, Hautier JM (2011) Propranolol appears to be an effective and well-tolerated treatment for ulcerated IH. J Am Acad Dermatol 64:827–832

    Article  Google Scholar 

  9. C McGrath PJ, Johnson G et al (1985) CHEOPS: A behavioral scale for rating postoperative pain in children. Adv Pain Research Therapy; 9: 395-402. (http://www.modernmedicine.com/sites/default/files/images/Resource-Centers/Children’s%20Hospital%20of%20Eastern%20Ontario%20Pain%20Scale%20(CHEOPS).pdf )

  10. Mitchell P (1999) Understanding a young child’s pain. Lancet 354:1708

    Article  CAS  PubMed  Google Scholar 

  11. Drolet BA, Esterly NB, Frieden IJ (1999) Hemangiomas in children. N Engl J Med 341(3):173–181

    Article  CAS  PubMed  Google Scholar 

  12. Bruckner AL, Frieden IJ (2003) Hemangiomas of infancy. J Am Acad Dermatol 48(4):477–493

    Article  PubMed  Google Scholar 

  13. Metz BJ, Rubenstein MC, Levy ML et al (2004) Response of ulcerated perineal hemangiomas of infancy to becaplermin gel, a recombinant human platelet-derived growth factor. Arch Dermatol 140:867–870

    PubMed  Google Scholar 

  14. Chamlin SL, Haggstrom AN, Drolet BA et al (2007) Multicenter prospective study of ulcerated hemangiomas. J Pediatr 151:684–689

    Article  PubMed  Google Scholar 

  15. Thomas RF, Hornung RL, Manning SC et al (2006) Hemangiomas of infancy: treatment of ulceration in the head and neck. Pediatrics 118(3):882–887

    Article  Google Scholar 

  16. Morelli JG, Tian Tan O, Yohn JJ (1994) Treatment of ulcerated hemangiomas in infancy. Arch Pediatr Adolesc 148:1104–1106

    Article  CAS  Google Scholar 

  17. Poetke M, Philipp C, Berlien HP (2000) Flashlamp-pumped pulsed dye laser for hemangiomas in infancy. Arch Dermatol 136:628–632

    CAS  PubMed  Google Scholar 

  18. Witman PM, Wagner AM, Scherer K et al (2006) Complications following pulsed dye laser treatment of superficial hemangiomas. Lasers Surg Med 38:116–123

    Article  PubMed  Google Scholar 

  19. Wasong SJ, Klepeiss SA, Zaenglein AL (2008) Picture of the month. Ulcerated infantile hemangioma. Arch Pediatr Adolesc Med 162(9):893–894

    Article  PubMed  Google Scholar 

  20. Sans V, Dumas DLR, Berge J et al (2009) Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 124:423–431

    Article  Google Scholar 

  21. Mousa W, Kues K, Haas E et al (2010) Successful treatment of a large hemangioma with propranolol. J Dtsch Dermatol Ges 8(3):184–186

    Article  PubMed  Google Scholar 

  22. D’Angelo G, Lee H, Weiner RI (1997) cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. J Cell Biochem 67:353–366

    Article  PubMed  Google Scholar 

  23. Sommers Smith SK, Smith DM (2002) Beta blockade induces apoptosis in cultured capillary endothelial cells. In Vitro Cell Dev Biol Anim 38:298–304

    Article  CAS  PubMed  Google Scholar 

  24. Hermans DJ, Boezeman JB, Van de Kerkhof PC, Rieu PN, Van der Vleuten CJ (2009) Differences between ulcerated and nonulcerated hemangiomas, a retrospective study of 465 cases. Eur J Dermatol 19:152–156

    PubMed  Google Scholar 

  25. Storch CH, Hoeger PH (2010) Propranolol for infantile hemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 163:269–274

    Article  CAS  PubMed  Google Scholar 

  26. Mohammadi AA, Bakhshaeekia A, Alibeigi P, Hasheminasab MJ, Tolide-ei HR, Tavakkolian AR et al (2009) Efficacy of propranololin wound healing for hospitalized burn patients. J Burn Care Res 30:1013–1017

    Article  PubMed  Google Scholar 

  27. Qin ZP, Liu XJ, Li KL, Zhou Q, Yang XJ, Zheng JW (2009) Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety. Zhonghua Yi Xue Za Zhi 89:3130–3134

    PubMed  Google Scholar 

  28. Pandey V, Tiwari P, Gangopadhyay AN, Gupta DK, Sharma SP, Kumar V (2014) Propranolol for infantile haemangiomas: experience from a tertiary center. J Cutan Aesthet Surg 7:37–41

    Article  PubMed Central  PubMed  Google Scholar 

  29. Bruckner AL, Frieden IJ (2003) Hemangiomas of infancy. J Am Acad Dermatol 48:477–493

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oral & Maxillofacial Surgery, Faculty of Dental Sciences, IMS, BHU, Varanasi, India

    Preeti Tiwari, Vaibhav Pandey, Ajay N. Gangopadhyay, Shiv P. Sharma & Dinesh K. Gupta

Authors
  1. Preeti Tiwari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vaibhav Pandey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ajay N. Gangopadhyay
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shiv P. Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dinesh K. Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Preeti Tiwari.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tiwari, P., Pandey, V., Gangopadhyay, A.N. et al. Role of propranolol in ulcerated haemangioma of head and neck: a prospective comparative study. Oral Maxillofac Surg 20, 73–77 (2016). https://doi.org/10.1007/s10006-015-0528-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10006-015-0528-z

Keywords

Search

Navigation